Share This Page:   

 

Browse by Clinical Topic:
Select a Topic to Learn More

Featured CME/CE Content:

 

neuroscienceCME Editors' Picks:

Focusing on Function with Patient-Centered Pain Care: Revised Guidelines for Opioid Prescribing

Premiere Date: Friday, October 21, 2022

This activity offers CE credit for:

1. ABIM (MOC)
2. Family Physicians (AAFP)
3. Medicine (accme)
4. Nursing (ANCC)
5. Pharmacy (acpe)
6. Psychological (apa)
7. Dentists (ADA CERP)
8. PA (aapa)
9. Other

All other clinicians will receive a Certificate of Attendance stating this activity was certified for AMA PRA Category 1 Credit™

Credit Expiration Date:
Saturday, October 21, 2023
Note: Credit Is No Longer Available

Faculty

Johnathan H. Goree, MD (Moderator) Service Line Director - Neurosciences Director of Chronic Pain Division Associate Professor of Anesthesiology University of Arkansas for Medical Sciences (UAMS) Little Rock, AR

Yvonne D'Arcy, MS, APRN-C, CNS, FAANP  Pain Management and Palliative Care Nurse Ponte Vedra Beach, FL

Melissa J. Durham, PharmD, MACM  Associate Professor of Clinical Pharmacy USC Mann School of Pharmacy and Pharmaceutical Sciences Clinical Pharmacist, The USC Pain Center Los Angeles, CA

Statement of Need

In 2016 the CDC Guideline for Prescribing Opioids for Chronic Pain was released with the goal of reducing rates of opioid use disorder (OUD) and overdose and encouraging use of effective opioid-alternatives for the management of chronic pain. In the first and second year following the Guidelines’ release, total day’s supply for opioid prescriptions were reduced by 4.7% and 9.8%, respectively, compared to the pre-Guideline period. However, misinterpretation and misapplication of guideline recommendations continues to pose health equity challenges and add frustration to patient-provider relationships. Updates to the aforementioned CDC Guidelines have been drafted to address these remaining barriers to safe, effective, and equitable pain management and will be released in late 2022.

In this recorded Risk Evaluation and Mitigation Strategy (REMS) webcast, faculty will review anticipated updates to the Guidelines and discuss how best to incorporate these updates into practice. The activity will also examine the underlying pathophysiologic mechanisms of pain, the identification and management of OUD, and strategies for educating patients about their pain and pain treatment options.

Learning Objectives

At the end of this CE activity, participants should be able to:

• Apply knowledge of acute and chronic pain pathways and underlying mechanisms to clinical assessment and appropriate management of pain.
• Incorporate the updated CDC Guideline for Prescribing Opioids to practice for safe and competent prescribing and improve health-related quality of life (HRQoL) for patients with chronic pain.
• Educate patients about their pain to optimize safe and effective, multimodal treatment plans.

Financial Support

This activity is supported by an independent educational grant from the Opioid Analgesic REMS Program Companies. Please click here for a listing of REMS Program Companies. This activity is intended to be fully compliant with the Opioid Analgesic REMS education requirements issued by the US Food and Drug Administration (FDA).

Target Audience

Physicians, psychologists, dentists, PAs, NPs, nurses, and pharmacists.

Credit Information

AAFP Credit (Family Physicians):
The AAFP has reviewed Focusing on Function with Patient-Centered Pain Care: Revised Guidelines for Opioid Prescribing (WCV-056) and deemed it acceptable for up to 1.50 Enduring Materials, Self-Study AAFP Prescribed credits. Term of Approval is from 10/31/2022 to 10/31/2023. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABIM MOC Credit:
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.5 medical knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Learning Formats
Enduring material

Royal College MOC:
Through an agreement between the Accreditation Council for Continuing Medical Education and the Royal College of Physicians and Surgeons of Canada, medical practitioners participating in the Royal College MOC Program may record completion of accredited activities registered under the ACCME’s “CME in Support of MOC” program in Section 3 of the Royal College’s MOC Program.

It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CE activity. CME Outfitters, LLC, has evaluated, identified, and mitigated any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process. The following information is for participant information only. It is not assumed that these relationships will have a negative impact on the presentations.

Dr. Goree reports the following financial relationships:.

Consultant: Abbott and Stratus Medical, LLC

Research Support: Mainstay Medical and SPR Therapeutics.

Dr. D'Arcy reports the following financial relationships:.

Advisory Board: AppliedVR, Inc.

Dr. Durham reports no financial relationships.

The following peer reviewer and CME Outfitters staff have no financial relationships:

Shirley Michelle Franks, MSN, APRN, FNP-BC (peer reviewer)

Thomas W. Heinrich, MD (peer reviewer AAFP)

Evan Luberger (planning committee)

Kellie Busby, PharmD (planning committee)

Kasey Brandt, PharmD (planning committee)

Susan H. Yarbrough, CHCP (planning committee)

Sandra Caballero, PharmD (planning committee)

Sharon Tordoff (planning committee)

Faculty of this CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices.

Questions about this activity? Call us at 877.CME.PROS (877.263.7767).